Content about Bayer

September 27, 2012
FDA approves new cancer drug

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

September 5, 2012
Bayer, Onyx seek approval for gastrointestinal tumor drug

Bayer HealthCare and Onyx Pharmaceuticals are seeking approval for a new drug to treat tumors of the gut, the companies said.

September 4, 2012
Bayer HealthCare brings OTC migraine relief to analgesic shelves

Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.

August 20, 2012
Bayer Aspirin emphasizes role of internal analgesic

Bayer has been stepping up its game behind its Bayer Advanced Aspirin brand in an attempt to recreate its brand identity from a healthy heart supplement for people who’ve had a heart attack to what Bayer Aspirin had been in its heyday: the internal analgesic of choice.

August 17, 2012
Plethora of probiotics
 entering market

The recent launch of a number of new probiotic products from several large suppliers should be a boon to the popular digestive-support supplement.

July 24, 2012
Kline: Recalls, economy and FSA prescription requirement driving store-brand OTC growth

Significant product recalls and the ongoing recession have driven consumer behavior change in the OTC aisle, according to a new report published Tuesday by Kline.

July 20, 2012
Pain Relief

The July/August 2012 Pain Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Aleve, Advil, Bayer Advanced, Perform, Absorbine, Salonpas, Hyland's Leg Cramps ointment, Arnicare and BenGay Cold Therapy.

June 29, 2012
FDA grants priority review for Bayer, Onyx cancer drug

The Food and Drug Administration has granted priority review for an investigational cancer treatment created by Bayer and Onyx Pharmaceuticals.

June 26, 2012
Bayer Advanced Aspirin, CC Sabathia kick off Fast Relief Challenge

Bayer Advanced Aspirin has tapped New York Yankees pitcher CC Sabathia for a consumer challenge and sweepstakes, which are designed to benefit the American Red Cross.

June 24, 2012
OTC Hot Products

According to DSN OTC expert Michael Johnsen, there is a great opportunity for all vendors to sell more by engaging with retailer education programs. Here are MJ's picks for hot products in health and wellness.

June 13, 2012
Bayer names Philip Blake to lead U.S. operations

Bayer on Tuesday announced that on July 1, Philip Blake will become senior Bayer representative USA, following a common company practice of assigning this oversight role to a senior executive already holding a significant business role or roles within the region.

June 4, 2012
Bayer gastrointestinal cancer drug extends progression-free survival in trial

An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

May 31, 2012
Actavis launches generic hypertension, chest pain drug

Actavis has launched a generic drug for high blood pressure and chest pain, the company said.

May 24, 2012
Bayer HealthCare submits approval application for colorectal cancer drug

Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.

May 16, 2012
Results from phase-3 trial of Pfizer cancer drug disappoint

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

April 20, 2012
Bayer donates $25,000 to benefit tornado victims

Bayer on Friday announced that it is providing monetary support for disaster relief efforts through a $25,000 donation from the Bayer USA Foundation to the American Red Cross of southwestern Indiana.

April 20, 2012
FDA approves Bayer blood-glucose monitoring system

Regulators have approved a new blood-glucose monitoring system made by Bayer HealthCare, the company said.

April 18, 2012
Bayer returning to pain relief heritage with Bayer Aspirin Fast Relief Challenge

To encourage consumers to rethink aspirin for pain relief — according to a recent Bayer survey, only 8% of respondents reported taking aspirin more often that other OTC pain relievers — Bayer on Tuesday issued the Fast Relief Challenge and is giving away 100,000 bottles of Bayer Advanced Aspirin so consumers can put the pain reliever to the test.

March 29, 2012
Kline unveils 2011 drivers of U.S. OTC market

The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

March 6, 2012
FDA approves lower dose of Bayer's Angeliq

The Food and Drug Administration has approved a new formulation of a drug for postmenopausal women.

January 19, 2012
Watson launches generic version of Bayer's Yaz

Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.

December 19, 2011
Goldstein Group unveils brand rejuvination for Bayer's Neo-Synephrine

Bayer recently engaged the Goldstein Group to rejuvenate the cough-cold Neo-Synephrine brand and improve the brand's identity on shelf.

November 28, 2011
Bayer's Aleve provides a little Kris Kringle pain relief in time for holidays

Bayer Healthcare on Monday announced its "Countdown to Holiday Cheer" sweepstakes in support of its Aleve brand.

November 28, 2011
Bayer, Regeneron start phase-3 trial of Eylea for wet AMD in China

Bayer HealthCare and Regeneron Pharmaceuticals have started a late-stage clinical trial in China to evaluate a drug for eye disorders, the companies said Monday.

November 17, 2011
Kline: Consumers gravitating toward 'natural' OTCs

Consumers are gravitating toward "natural" over-the-counter remedies, according to a new Kline report, "Natural OTCs 2011: Impact of Non-Drug Products on the U.S. OTC Market," released Wednesday.

© 2013 Drug Store News. All Rights Reserved.